LOAMU
LRMR icon

Lombard Odier Asset Management (USA)’s Larimar Therapeutics LRMR Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,941
Closed -$3.43M – 180
2015
Q3 		$3.43M Buy
8,941
+388
+5% +$175K 0.3% 111
2015
Q2 		$3.55M Sell
8,553
-2,958
-26% -$1.24M 0.25% 130
2015
Q1 		$5.47M Buy
11,511
+2,495
+28% +$1.18M 0.44% 87
2014
Q4 		$3.34M Buy
9,016
+272
+3% +$70.1K 0.23% 113
2014
Q3 		$2.06M Buy
+8,744
New +$1.98M 0.14% 146

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s LRMR Position: Q4 2015 in Review

Lombard Odier Asset Management (USA) sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 8,941 shares — an estimated $3.43M sold.

Lombard Odier Asset Management (USA) first reported a position in LRMR in Q3 2014 and held it in 5 quarters. The position peaked at $5.47M in Q1 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Lombard Odier Asset Management (USA) reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 8,941 Larimar Therapeutics shares in Q4 2015, an estimated $3.43M.
  • Lombard Odier Asset Management (USA) first reported a position in Larimar Therapeutics in Q3 2014 and held it in 5 quarters.
  • Lombard Odier Asset Management (USA)'s Larimar Therapeutics position peaked at $5.47M in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2015, filed 16 Feb 2016.